All Stories

Atea offloads a quarter of its workforce, gears up for phase 3 HCV trials

Atea Pharmaceuticals has laid off a quarter of its workforce so far this year as the biotech prepares to launch a phase 3 trial of its hepatitis C cocktail.

Mar 7, 2025 - 12:13
 0
Atea offloads a quarter of its workforce, gears up for phase 3 HCV trials
Atea Pharmaceuticals has laid off a quarter of its workforce so far this year as the biotech prepares to launch a phase 3 trial of its hepatitis C cocktail.
Read More

Tags:

Previous Article

Bowker sharpens focus on Bolton centre, forecasts 20% growth in used sales

Next Article

Britannia Industries CEO Rajneet Kohli resigns 

Related Posts

Options shrink for Supernus depression drug candidate after key trial failure

Options shrink for Supernus depression drug candidate a...

Feb 19, 2025  0

GSK plans to move vaccine R&D center from Rockville, Maryland, to the Boston area

GSK plans to move vaccine R&D center from Rockville, Ma...

Feb 12, 2025  0

Zymeworks pauses plans to launch one ADC into clinic in favor of another asset

Zymeworks pauses plans to launch one ADC into clinic in...

Mar 6, 2025  0